Glipizide Tablet, Extended Release
Product Images NDC 82868-025

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 82868-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 025 90 Rev A 11 23)

Label for Glipizide Extended-Release Tablets, 5 mg, oral dosage form. The label indicates a package size of 90 tablets, Rx only, with storage instructions at 20°-25°C. Manufactured by Northwind Health Company, LLC, NDC 82868-025. The label includes warnings about keeping out of reach of children and protecting from moisture and humidity.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide, as depicted in the image. The diagram shows the molecular arrangement including rings, functional groups, and bonds typical for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.